Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candid... (mpany received approval of its Investiga...)

Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344

Date:5/29/2012

mpany received approval of its Investigational New Drug application for ME-344 in April 2012 and initiated a Phase I clinical trial of intravenous ME-344 in patients with solid refractory tumors shortly thereafter. For more information, please visit www.marshalledwardsinc.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties or differences in interpretation in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing; technological changes; government regulation; changes in industry practic
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
2. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
3. Marshall Edwards Submits Investigational New Drug Application for Oncology Drug Candidate ME-344
4. Marshall Edwards CEO to Present at Roth Capital Partners Growth Stock Conference
5. Marshall Edwards Announces Rights Offering to Stockholders
6. Marshall Edwards Adds $2 Million in Private Placement
7. Marshall Edwards Announces $2 Million Private Placement
8. Marshall Edwards Announces First Patient Dosed in Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
9. Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
10. Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143
11. Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells

Post Your Comments:

(Date:5/21/2013)... 2013 New data released today at ... show that the NeuroStar TMS Therapy System ® ... remission in patients with Major Depressive Disorder (MDD) ... maintained through one year of treatment. At the ... achieved symptomatic improvement while 41 percent reported complete ...

(Date:5/21/2013)... 2013 Lakeland Industries, Inc. (NASDAQ: ... protective clothing for industry, municipalities, healthcare and first ... today announced that the Company accepted a commitment ... Facility subject to certain terms and conditions and ... no assurances can be given that this transaction ...

(Date:5/21/2013)... 21, 2013 Regulus Therapeutics Inc . ( ... and development of innovative medicines targeting microRNAs, today announced ... Chief Operating Officer and Executive Vice President, Finance, will ... Annual Healthcare Conference on Wednesday, May 29, 2013 at ... the Westin Boston Waterfront Hotel. The presentation ...

[0] New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System [0] Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results [0] Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference

... March 12 Genta,Incorporated (Nasdaq: GNTA ) today announced ... 31, 2007. The Company noted,significant recent milestones, including:, ... biomarker initiates in melanoma -- New oral product, ... 505(b)(2) strategy -- Tesetaxel, a leading ...

... Achieve Weight Loss with Education & ... ... Findings in the Journal of,the American Medical Association on the largest ... prevention.,The combination of both personal contact and web-based support are,identified as ...

Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights Study Finds Personal and Web-Based Support Equal Weight Loss Success

(Date:5/21/2013)... of the adenoids and tonsils, is performed 500,000 times ... treatment for children with obstructive sleep apnea. However, ... executive functioning, behavior, sleep apnea symptoms, and quality of ... A study led by Susan Redline, MD, MPH, ... and Associate Clinic Director of the Division of Sleep ...

(Date:5/21/2013)... 21, 2013 The Las Vegas personal injury ... announce that Crawford Gates, a senior at Coronado High School, ... scholarship essay contest . As the winner of the essay ... contest started on Dec. 1, 2012 and ran through April ... submit a three-page minimum essay on “The Role of the ...

(Date:5/21/2013)... Harbor, Florida (PRWEB) May 21, 2013 ... agency, announced today that they have redesigned their website ... a nude beach, pool, hot tubs, bars and dining. ... this nudist resort including sales and guest reviews, will ... island of Jamaica itself, including pages on culinary local ...

(Date:5/21/2013)... A new study appearing in the current ... cells harvested from fat (adipose) are more potent than ... the body’s immune system. , The finding could ... adipose tissue-derived stem cells (AT-SCs) are far more plentiful ... and can be collected from waste material from liposuction ...

(Date:5/21/2013)... 21, 2013 The American Diabetes Association ... in the United States of America are affected with ... a great risk of developing peripheral neuropathy which unfortunately ... The ADA further goes on saying that the disease ... around 2 million new cases are diagnosed every year ...

Breaking Medicine News(10 mins):Health News:Early removal of adenoids and tonsils can help pediatric sleep apnea symptoms 2 Health News:Benson, Bertoldo, Baker & Carter is Pleased to Announce the Winner of its First Annual College Scholarship Essay Contest 2 Health News:The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography 2 Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 2 Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 3 Health News:Neuracel Aims to Reduce Peripheral Neuropathy Pain 2

[0] Early removal of adenoids and tonsils can help pediatric sleep apnea symptoms [0] Benson, Bertoldo, Baker & Carter is Pleased to Announce the Winner of its First Annual College Scholarship Essay Contest [0] The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography [0] Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease [0] Neuracel Aims to Reduce Peripheral Neuropathy Pain

... Texas to Receive this Honor, AUSTIN, Texas, May ... announced today that the hospital network was,selected as one ... the highest honor bestowed by the State of Texas ... by the Quality Texas Foundation, is based on St.,David,s ...

... Major Part of Unprecedented ,Justice for,All, Plan to Change ... million, mobilize tens of,thousands during and AFTER the election ... May 8 Members and leaders of the,nation,s strongest ... strictly accountable if they say one thing before an ...

... GHX electronic trading exchange enables fully ... May 8 GHX Mobile Solutions today,announced that ... SalesAccelerator,handheld inventory management tool that can now read ... capability, healthcare manufacturers can,more broadly utilize SalesAccelerator to ...

... Who says the best,times of your life have already ... (http://www.HealthCentral.com ) has recently,brought on The Midlife Gals, two ... the responsibility of caring for their elderly mother,comes the ... face of others., Known for their personal blog, ...

... Webcast and Archived Replay Instructions Below, SAN ... MXWL ) will conduct its Annual Meeting of ... Spectrum Center Drive., For those who are ... live,via the following link:, http://www.maxwell.com/investors/investor-calendar.asp . The webcast ...

... SAN DIEGO (May 8, 2008) The La Jolla ... $7.1 million grant from the National Institutes of Health ... antibody treatment that quickly fights the smallpox virus. ... defense in protecting against a terrorist-originated smallpox outbreak and ...

Cached Medicine News:Health News:St. David's HealthCare Granted the State's Top Honor for Quality and Performance Excellence 2 Health News:St. David's HealthCare Granted the State's Top Honor for Quality and Performance Excellence 3 Health News:SEIU Members to Politicians: Live Up to Your Promises or We Will Hold You Accountable 2 Health News:SEIU Members to Politicians: Live Up to Your Promises or We Will Hold You Accountable 3 Health News:SEIU Members to Politicians: Live Up to Your Promises or We Will Hold You Accountable 4 Health News:GHX Mobile Solutions' SalesAccelerator Tool Adds Capability to Read RFID Tags, as Well as Barcodes 2 Health News:The HealthCentral Network Signs Spunky 'Midlife Gals' for Comedic Relief on Alzheimer's, Skin Care Sites 2 Health News:NIH awards LIAI major grant to test safety of new smallpox treatment 2 Health News:NIH awards LIAI major grant to test safety of new smallpox treatment 3

St. David's HealthCare Granted the State's Top Honor for Quality and Performance Excellence SEIU Members to Politicians: Live Up to Your Promises or We Will Hold You Accountable GHX Mobile Solutions' SalesAccelerator Tool Adds Capability to Read RFID Tags, as Well as Barcodes The HealthCentral Network Signs Spunky 'Midlife Gals' for Comedic Relief on Alzheimer's, Skin Care Sites Maxwell Technologies' Annual Meeting Today in San Diego NIH awards LIAI major grant to test safety of new smallpox treatment

... performing of plugs and allow precise control of ... and sorting. Colored graduations are enameled onto the ... calibrated "To Deliver" its total capacity when the ... L 8 350 mm Measur range: ...

... opening allows more rapid intake and delivery of ... onto the glass. Two narrow bands or one ... is calibrated"To Deliver"its total capacity when the last ... 350 mm graduations and accuracy 0-4.9 0.1 ...

Corning 7078 Calibrated"to deliver". multi-pack plugged capacity 5 mL...

... These disposable 0.5mL PYREX glass ... (TD) with blow-out and offer ... make pipetting go faster and ... graduations and fire polished tips ...

Medicine Products:

Pyrex brand reusable serological pipet, color-coded, for cotton plugging Pyrex brand reusable serological pipet, color-coded, large tip opening Pyrex brand serological disposable pipettes, sterile, multi-pack Pyrex brand serological, disposable, non-sterile, non-plugged pipettes